Barclays Reiterates Underweight Rating on The Clorox Company (CLX)

Market Context

The Clorox Company operates in the Consumer Defensive sector. The stock currently trades at $87.09 with a market capitalization of $12.5B. The stock has declined 12.3% over the past 52 weeks.

Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for The Clorox Company.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for The Clorox Company

Among the 10 most recent ratings: 0 Buy, 8 Hold, 2 Sell.

Date	Firm	Rating	Price Target
Oct 16, 2026	Barclays	Underweight	N/A
Oct 15, 2026	Morgan Stanley	Equal-Weight	N/A
Oct 14, 2026	Citigroup	Neutral	N/A
Oct 13, 2026	TD Cowen	Hold	N/A
Oct 05, 2026	Wells Fargo	Equal-Weight	N/A

Related Tools: Analyst Ratings Dashboard | View CLX Stock Page